# Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Moist Wound Healing Dressing Alone in Accelerating the Epithelialization of Split Thickness Skin Graft Donor Sites

> **NCT01294254** · PHASE2 · COMPLETED · sponsor: **Birken AG** · enrollment: 24 (actual)

## Conditions studied

- Accelerating the Epithelialization of Split Thickness Skin Graft

## Interventions

- **DRUG:** Oleogel-S10
- **PROCEDURE:** Moist wound healing dressings alone (Mepilex) on the other half of the skin graft donor site

## Key facts

- **NCT ID:** NCT01294254
- **Lead sponsor:** Birken AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01294254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01294254, "Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Moist Wound Healing Dressing Alone in Accelerating the Epithelialization of Split Thickness Skin Graft Donor Sites". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01294254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*